1. Home
  2. FVCB vs ELDN Comparison

FVCB vs ELDN Comparison

Compare FVCB & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FVCBankcorp Inc.

FVCB

FVCBankcorp Inc.

SELL

Current Price

$17.52

Market Cap

338.0M

Sector

Finance

ML Signal

SELL

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

SELL

Current Price

$2.13

Market Cap

291.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FVCB
ELDN
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
338.0M
291.8M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
FVCB
ELDN
Price
$17.52
$2.13
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
★ $19.38
$9.00
AVG Volume (30 Days)
55.9K
★ 758.2K
Earning Date
10-27-2026
11-13-2026
Dividend Yield
★ 1.60%
N/A
EPS Growth
★ 47.56
30.67
EPS
★ 0.81
N/A
Revenue
★ $1,781,000.00
N/A
Revenue This Year
$19.14
N/A
Revenue Next Year
$9.11
N/A
P/E Ratio
$21.64
★ N/A
Revenue Growth
★ 13.87
N/A
52 Week Low
$11.83
$1.35
52 Week High
$19.11
$4.60

Technical Indicators

Market Signals
Indicator
FVCB
ELDN
Relative Strength Index (RSI) 45.60 25.06
Support Level $17.28 $1.96
Resistance Level $18.01 $2.30
Average True Range (ATR) 0.34 0.13
MACD 0.01 -0.00
Stochastic Oscillator 52.69 6.00

Price Performance

Historical Comparison
FVCB
ELDN

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: